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Bicuspid Aortic Valve and Aortopathy:
See the First, Then Look at the Second*
Rosario V. Freeman, MD, MS, Catherine M. Otto, MD
Seattle, Washingtonb
a
v
f
t
p
p
b
t
c
i
t
s
a
i
9
t
a
h
a
a
(
p
c
H
u
e
c
D
n
c
o
c
b
d
aBicuspid aortic valve (BAV) disease is the most
common congenital cardiac anomaly, with a prev-
alence in the general population between 0.5% and
2% (1). There is significant cardiac morbidity asso-
ciated with BAV disease, predominantly due to
progressive valve dysfunction (stenosis or regurgita-
tion) that requires surgical intervention for symp-
tom relief or prevention of left ventricular dysfunc-
tion, or less commonly, for complications of
endocarditis (2,3). We now understand that BAV
disease is more than simply having 2, instead of 3,
aortic valve leaflets. BAV disease encompasses a
spectrum of phenotypic manifestations that not
only includes valve dysfunction, but also abnormal-
ities of the ascending aorta. Less common cardio-
vascular abnormalities may also occur, such as aortic
coarctation, atrial septal defects, and ventricular
septal defects.
See page 150
Long-term cardiovascular outcomes in adults with
a BAV were defined in 2 recent clinical studies. In a
series of 642 asymptomatic adults with a BAV, most
(63%) had normal or mildly abnormal valve function
at baseline. Over an average 9 years of follow-up,
about 25% required surgery for symptomatic valve
disease, left ventricular dysfunction, ascending aor-
tic dilation, or endocarditis. Independent predictors
of adverse cardiovascular events were age 30 years
and at least moderate aortic valve dysfunction at
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symptomatic adults with a BAV and at most mild
alve dysfunction, primary cardiac outcomes were
requent over follow-up, occurring in 42% of par-
icipants. In this study, independent predictors for
rimary outcomes were older age (50 years),
resence of valve degeneration at baseline, and a
aseline aortic dimension of 40 mm (2). Impor-
antly, these studies demonstrated that although the
ardiac morbidity associated with a BAV is signif-
cant, overall life expectancy is not shortened rela-
ive to general population estimates. In the Olm-
tead County study, survival was 97% and 90% at 10
nd 20 years, respectively, from diagnosis (2). Sim-
larly, in the Toronto cohort, 10-year survival was
7% (3).
BAV disease is not confined to the valve leaflets;
he aorta also is abnormal. Compared with normal
dults with a trileaflet aortic valve, BAV patients
ave larger dimensions of the aortic sinuses and
scending aorta, abnormal aortic elasticity, and are
t risk for progressive aortic dilation and dissection
4). In the past, aortic dilation was thought to be
rimarily a hemodynamic consequence of the ec-
entric ejection jet created by the bicuspid valve.
owever, histopathologic studies now support an
nderlying connective tissue disease process with
lastin fragmentation, irregularities in smooth mus-
le integrity, and increased collagen deposition (5).
ilation is often progressive, with an average an-
ual change in diameter ranging from 0.2 to 1.2
m/year (6). Risk factors for more rapid progression
f aortic dilation include hypertension, male sex,
oncurrent valve disease, and older age. In the study
y Tzemos et al. (3), 280 patients (45%) developed
ilation of the aortic sinus, ascending aorta, or both
t follow-up. In a subsequent publication from the
lmstead County cohort, which included 416 pa-
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163tients, although 53% of patients eventually required
aortic valve replacement, a significant portion of
patients (25%) also ultimately required surgical
intervention for aortopathy (6). Because not all
patients are at risk for progressive aortic dilation,
the clinical challenge is in identifying which pa-
tients are at highest risk for aortic complications
and might therefore require more frequent imaging
evaluation.
In this issue of iJACC, a study by Kang et al. (7)
focuses on the potential value of computed tomo-
graphic angiography (CTA) to more precisely de-
fine BAV phenotypes and to characterize the asso-
ciated aortopathy. Typically, bicuspid valve cusps
are asymmetric with fusion along a commissural
line, which creates 2 cusps of unequal size. Similar
to other series, this study found that fusion of the
right and left coronary cusps (anterior–posterior
[AP] leaflet type) was the most common pattern,
occurring in 56% of patients, with fusion of the
right and noncoronary cusps (right–left [RL] leaflet
type) seen in the remaining 44% of patients. Al-
though the study suggests that the RL phenotype is
associated with valve stenosis and the AP pheno-
type with regurgitation, this should be considered a
hypothesis, not a conclusion. All the subjects in this
study were referred for preoperative CTA; thus, all
had significant valve dysfunction and/or aortic di-
lation and should not be considered representative
of an unselected group of BAV patients. Kang et al.
(7) also found that leaflet phenotype was associated
with different patterns of aortic dilation. Normal
aortic shape and dimensions were seen more often
in BAV patients with an AP leaflet phenotype,
whereas those with a RL leaflet phenotype more
often had aortic dilation extending to the arch.
These findings parallel a study from our group that
demonstrated larger and stiffer aortic sinuses with
the AP phenotype and larger aortic arch dimensions
with the RL leaflet phenotype (8,9). These differ-
ences in aortic anatomy and valve function associ-
ated with different valve phenotypes support the
possibility that BAV disease is not a uniform
disease process.
Despite the insights into the disease process
provided by this study, which was performed with
computed tomography, from a practical point of
view, echocardiography remains the key imaging
approach in adults with BAV disease. CTA is only
an adjunct in selected patients. BAV disease is
usually asymptomatic, often incidentally diagnosed
on echocardiography obtained for other indications
or suspected on physical examination with auscul-tation of a murmur or a mid-systolic “click.” Trans-
thoracic echocardiography has a high sensitivity and
specificity for the diagnosis of a BAV. Character-
istic findings include an eccentric diastolic leaflet
closure plane and systolic doming of the leaflets in
long-axis views. The number of valve leaflets, the
type of leaflet fusion, and the presence or absence of
a raphe can be reliably determined in short-axis
views. Doppler echocardiography allows accurate
measurement of the severity of valve stenosis and
regurgitation. If transthoracic image quality is not
adequate, transesophageal echocardiography often
provides improved visualization of aortic leaflet
morphology. Three-dimensional imaging of the
aortic valve may further improve the accuracy of
echocardiography for diagnosis of BAV disease.
Echocardiography allows evaluation of the aortic
sinuses and, by moving the transducer up 1 inter-
costal space, the proximal ascending aorta. Because
of the low cost, lack of ionizing radiation, and wide
availability, echocardiography is often used to eval-
uate and follow the aortopathy associated with
BAV disease. However, for a more comprehensive
evaluation of aortic anatomy, CTA or magnetic
resonance angiography (MRA) both provide com-
prehensive tomographic evaluation of the entire
aorta, and are particularly helpful when visualiza-
tion of the ascending aorta by echocardiography is
limited. Our approach in patients newly diagnosed
with BAV is to obtain an index tomographic (CTA
or MRA) imaging study of the aorta to determine
the pattern and severity of aortic dilation. If there is
no significant dilation or if echocardiography ade-
quately visualizes the aorta, then serial routine CTA
or MRA imaging is not indicated. In patients who
have disease progression necessitating aortic valve
replacement, aortic surgery, or both, pre-surgical
CTA or MRA imaging provides a better under-
standing of the extent of aortic involvement to aid
in surgical planning and graft choice.
A majority of patients with BAV disease will
have disease progression requiring surgery over the
course of their lifetime, most often for valve stenosis
or regurgitation, with established clinical guidelines
providing recommendations on optimal timing of
intervention (10). Clinical recommendations for
surgical intervention for the aortopathy associated
with BAV disease are less well defined, but most
centers recommend intervention at an aortic diam-
eter greater than 50 to 55 mm, independent of
valve disease. Aortic graft replacement may also be
considered at a smaller aortic diameter (45 to 50
mm) in patients who are otherwise undergoing
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164aortic valve surgery or if there is evidence of rapid
disease progression (interval increase in aortic di-
ameter 5 mm over 6 months.)
Although adults with BAV disease can have
excellent clinical outcomes with appropriate disease
monitoring and with correctly timed intervention to
prevent adverse events, our current approach is
largely pragmatic with little understanding of the
underlying disease process. Several studies, such as
the one by Kang et al. (7), suggest that there is more
than 1 BAV phenotype with different clinical asso-MR. The bicuspid aortic valve. Curr
Probl Cardiol 2005;30:470–522.
cending aorta. Am
686–90.different genetics and different clinical outcomes?
Until we can identify which patients with BAV
disease are at risk for aortic dissection and would
benefit from prophylactic aortic intervention, we
will need to continue serial imaging of all BAV
patients to detect the few who have progressed to
surgical disease.
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